VIATRIS INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
VIATRIS INC. (VTRS) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 100 shares for the 3-month period ending 2020-09-27, per its 10-Q filed 2020-11-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2020-11-10
- VIATRIS INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-27 was 100.00 shares, a 0.00% change year-over-year.
- VIATRIS INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-06-28 was 100.00 shares, a 0.00% change year-over-year.
- VIATRIS INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-09-29 was 100.00 shares.
- VIATRIS INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-06-30 was 100.00 shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 4 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 7 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month |
|---|---|---|---|---|---|
| 2020-09-27 | 100.00 shares 10-Q · filed 2020-11-10 | 100.00 shares derived: average of 2 quarters · filed 2020-11-10 | 100.00 shares 10-Q · filed 2020-11-10 | ||
| 2020-06-28 | 100.00 shares 10-Q · filed 2020-08-12 | 100.00 shares 10-Q · filed 2020-08-12 | |||
| 2019-09-29 | 100.00 shares 10-Q · filed 2020-11-10 | 100.00 shares derived: average of 2 quarters · filed 2020-11-10 | 100.00 shares 10-Q · filed 2020-11-10 | ||
| 2019-06-30 | 100.00 shares 10-Q · filed 2020-08-12 | 100.00 shares 10-Q · filed 2020-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |